Abiopharma

🔍 PROKOPANKO JAMES T (Executive)

Company: Vulcan Materials CO (VMC)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Acquired 617 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-08 | Code: A | Exercise: 2027-05-08 | equity_swap_involved: false | shares_owned_after: 617.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3

Footnotes:

• F1: Each Restricted Stock Unit represents a contingent right to receive one share of Vulcan Common Stock.
• F2: Annual stock grant made to the reporting person under the Vulcan Materials Company 2025 Omnibus Long-Term Incentive Plan.
• F3: Restricted Stock Units cliff vest on the specified date. In accordance with the terms of the Vulcan Materials Company 2025 Omnibus Long-Term Incentive Plan and instructions previously provided by the reporting person pursuant thereto, vested Restricted Stock Units will be delivered to the reporting person when the reporting person ceases to hold office as a member of the Board of Directors of Vulcan Materials Company.